Key result
The 2017 ESC/EACTS guidelines and recent clinical studies highlight the expanding role of transcatheter valve treatments and updated indications for surgery in valvular heart disease.
This review highlights key updates in the 2017 ESC/EACTS guidelines for valvular heart disease, particularly regarding transcatheter interventions and the establishment of multidisciplinary Heart Valve Centres.
2017 ESC/EACTS valvular guidelines update TAVI and surgical indications; leaves open prospective validation in local cohorts.
Uvod Europsko kardiološko društvo (ESC prema engl.European Society of Cardiology) i Europsko udruženje kardiotorakalnih kirurga (EACTS prema engl.European Association of Cardiothoracic Surgeons) objavili su 2017.godine smjernice za liječenje bolesti srčanih zalistaka.1 Nove su smjernice sažetije i nadovezuju se na udžbenik Europskog kardiološkog društva koji je u izradi.Glavne se promjene odnose na transkatetersko liječenje bolesti srčanih zalistaka te na indikacije za kirurško i medikamentno liječenje.Smjernice predstavljaju novi koncept centara za srčane zalistke s preporukom kriterija koje takvi centri moraju zadovoljiti, a koji uključuju multidisciplinarne timove kompetentne u različitim intervencijama i tehnikama u dijagnostici i liječenju bolesti srčanih zalistaka, uz dostupnost važnih suradnih usluga, standardizirane procese i procjenu učinka. 2 Neke od promjena u posljednjim smjernicama istaknute su u ovome članku.preamble A new joint European Society of Cardiology (ESC) and European Association of Cardiothoracic Surgeons (EACTS) guidelines on management of valvular heart disease (VHD) was published in 2017. 1 These guidelines are more focused, and are linked to the upcoming ESC textbook.The main changes concern the role of transcatheter valve treatment, indications for surgery as well as medical therapy.The guidelines present a new concept of Heart Valve Centres with recommended requirements, including multidisciplinary teams with competencies in various interventions and diagnostic techniques for VHD, the availability of important collaborative services, standardized processes and recording of performance data. 2 Some of changes in the latest guidelines are highlighted in this article.
No takes yet. Share an insight, caveat, or question.
Søndergaard et al. (2018) conducted a review in Valvular heart disease. The 2017 ESC/EACTS guidelines and recent clinical studies highlight the expanding role of transcatheter valve treatments and updated indications for surgery in valvular heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: